Recommended Topic Related To:

Optivar

"Feb. 25, 2013 (San Antonio, Texas) -- The asthma drug Xolair appears to be a safe and effective treatment for chronic hives, a new study shows.

The results of the study were presented at a news conference here at the American Academy"...

Optivar

Indications
Dosage
How Supplied

INDICATIONS

OPTIVAR (azelastine hydrochloride) ® is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop instilled into each affected eye twice a day.

HOW SUPPLIED

OPTIVAR® (azelastine hydrochloride ophthalmic solution), 0.05% is supplied as follows:

OPTIVAR (azelastine hydrochloride) ® 6 mL (NDC#0037-7025-60) solution in a translucent 10 mL HDPE container with a LDPE dropper tip and a white HDPE screw cap.

OPTIVAR (azelastine hydrochloride) ® 0.2 mL (NDC#0037-7025-01) solution in a translucent 1 mL HDPE single-use container, packaged as 4 single-use containers in a foil pouch in a carton.

Attention

Once OPTIVAR (azelastine hydrochloride) ® 0.2 mL unit dose foil pouch is open, unopened containers can be used for one month, not to exceed the expiration date imprinted on the container. After one month they should be discarded. Use only if foil pouch is sealed and single container is intact. Discard each container immediately after use.

Storage

OPTIVAR (azelastine hydrochloride) ® 6 mL container: Store UPRIGHT between 2° and 25°C (36° and 77°F).
OPTIVAR (azelastine hydrochloride) ® 0.2 mL container: Store at controlled room temperature 20°-25°C (68° -77°F).

OPTIVAR (azelastine hydrochloride) ® 6 mL container Manufactured by: Patheon UK Ltd., Swindon, United Kingdom. OPTIVAR (azelastine hydrochloride) ® 0.2 mL container Manufactured by: Catalent Pharma Solutions, Woodstock, Illinois, USA. Distributed by: Meda Pharmaceuticals™, Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120. OPTIVAR (azelastine hydrochloride) ® 6 ml container Made in United Kingdom. OPTIVAR (azelastine hydrochloride) ® 0.2 mL Made in United States. Issued 06/2008. FDA revision date: 07/02/08

Last reviewed on RxList: 8/5/2008
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Optivar - User Reviews

Optivar User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Optivar sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.


NIH talks about Ebola on WebMD